The Motley Fool

FTSE 100 falls to two month low! Here’s how I’d invest £1,000 in an ISA today

July’s been a poor month for the FTSE 100. The index fell below 6,000 for the first time since 22 May at its close on Thursday. It also closed at the lowest since mid-May or in two-and-a-half months. There’s more. After two straight months of gains, the index average in July fell by 1%.

Poor performances drag down FTSE 100

There’s a bunch of reasons for the latest tumble, the first of which is a poor set of financial results by FTSE 100 heavyweights like Lloyds Bank and Royal Dutch Shell, which both posted a sharp contraction in income. In LLOY’s case, there’s actually a pre-tax loss. Moreover, banks like HSBC and Standard Chartered find themselves caught in the US-China trade tensions as the second cold war gets more real by the day. News from the global economy wasn’t exactly encouraging either. The US economy shrank the most on record and the German economy contracted too, pulling world indexes down as well. 

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Investing in the ‘new normal’

I wish I could say otherwise, but I doubt if this situation will be resolved soon. In other words, I think investors are looking at a rapidly evolving ‘new normal’ in which to navigate their stock market decisions. What makes this the ‘new normal’? One, the pandemic has been controlled to an extent but, until such time as there’s a vaccine or cure for Covid-19, fluctuations in the markets can be expected. Two, the economic aftermath of the pandemic is yet to play out. I think that economic weakness will continue well into 2021, which will also create uncertainty in the FTSE 100 index. Third, continued tensions between the US and China on the one hand and Brexit uncertainty on the other will also keep the index in a range. 

Where I would invest £1,000

However, I don’t think what’s true for the broader index is necessarily so for all its constituents. Many FTSE 100 companies continue to be high performers even during this time. Consider pharmaceutical companies like AstraZeneca and Hikma Pharmaceuticals, which were gainers at Thursday’s close. It’s not a coincidence. They are financially healthy companies with good prospects. The pest control and hygiene services provider Rentokil Initial was another gainer, for the same reasons

One reason investors could be hesitant to buy these stocks is that their prices have already run up quite a bit already. Going by the price-to-earnings (P/E) ratio, AZN is quite expensive. RTO too, isn’t among the most price-competitive stocks. However, others like HIK are relatively cheap, with a P/E of 11 times. 

I think it’s also a good time to dip a toe back in cyclicals. Correction in some sectors has been quite dramatic, and because of this, I think they can make gains even in an otherwise indifferent environment. I like companies such as Persimmon and Barratt Developments, which have suffered along with the rest of the property segment. I  think FTSE 250 companies like Marshalls and Bellway are also ones to consider for investing £1,000 in an ISA.

A Top Share with Enormous Growth Potential

Savvy investors like you won’t want to miss out on this timely opportunity…

Here’s your chance to discover exactly what has got our Motley Fool UK analyst all fired up about this ‘pure-play’ online business (yes, despite the pandemic!).

Not only does this company enjoy a dominant market-leading position…

But its capital-light, highly scalable business model has previously helped it deliver consistently high sales, astounding near-70% margins, and rising shareholder returns … in fact, in 2019 it returned a whopping £150m+ to shareholders in dividends and buybacks!

And here’s the really exciting part…

While COVID-19 may have thrown the company a curveball, management have acted swiftly to ensure this business is as well placed as it can be to ride out the current period of uncertainty… in fact, our analyst believes it should come roaring back to life, just as soon as normal economic activity resumes.

That’s why we think now could be the perfect time for you to start building your own stake in this exceptional business – especially given the shares look to be trading on a fairly undemanding valuation for the year to March 2021.

Click here to claim your copy of this special report now — and we’ll tell you the name of this Top Growth Share… free of charge!

Manika Premsingh owns shares of AstraZeneca. The Motley Fool UK has recommended Hikma Pharmaceuticals, HSBC Holdings, and Standard Chartered. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.